LivaNova PLC (LIVN)
NASDAQ: LIVN · Real-Time Price · USD
52.15
-0.48 (-0.91%)
At close: Oct 7, 2025, 4:00 PM EDT
52.15
0.00 (0.00%)
After-hours: Oct 7, 2025, 4:00 PM EDT
LivaNova Market Cap
LivaNova has a market cap or net worth of $2.85 billion as of October 7, 2025. Its market cap has increased by 2.36% in one year.
Market Cap
2.85B
Enterprise Value
2.74B
1-Year Change
2.36%
Ranking
Category
Stock Price
$52.15
Market Cap Chart
Since October 19, 2015, LivaNova's market cap has decreased from $3.42B to $2.85B, a decrease of -16.63%. That is a compound annual growth rate of -1.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 2.87B | 14.28% |
| Dec 31, 2024 | 2.51B | -9.78% |
| Dec 29, 2023 | 2.79B | -6.24% |
| Dec 30, 2022 | 2.97B | -36.12% |
| Dec 31, 2021 | 4.65B | 44.63% |
| Dec 31, 2020 | 3.22B | -11.87% |
| Dec 31, 2019 | 3.65B | -18.02% |
| Dec 31, 2018 | 4.45B | 15.57% |
| Dec 29, 2017 | 3.85B | 75.67% |
| Dec 30, 2016 | 2.19B | -24.35% |
| Dec 31, 2015 | 2.90B | -15.10% |
| Oct 19, 2015 | 3.42B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |